Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-051999

Director sold 4,500 shares at $56.81 ($255,645)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CHESS ROBERT Director 2018-09-19 Sale −4,500 $56.81 $255,645 269,723 D: show line 1 in the form
Open-market sales · 4,500 sh · avg $56.81 · $255,645
Loading xslF345X03/doc4.xml…